Author/Creator: Vugmeyster, Yulia - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Vugmeyster, Yulia

1. 265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort. (9th November 2020)

Authors:: Deville, Jean-Laurent; Ravaud, Alain; Maruzzo, Marco; Gourdin, Theodore; Maio, Michele; Dirix, Luc; Wang, XiaoZhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Jeorg; Chennoufi, Sarah; Gulley, James
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8(2020)Supplement 3
Page Start:: A291
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. 265 Phase 1b study of avelumab + M9241 (NHS-IL12) in patients with advanced solid tumors: interim analysis results from a urothelial carcinoma (UC) dose-expansion cohort. (9th November 2020)

Authors:: Deville, Jean-Laurent; Ravaud, Alain; Maruzzo, Marco; Gourdin, Theodore; Maio, Michele; Dirix, Luc; Wang, XiaoZhe; Vugmeyster, Yulia; Beier, Frank; Seebeck, Jeorg; Chennoufi, Sarah; Gulley, James
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 8(2020)Supplement 3
Page Start:: A163
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Characterizing Exposure–Response Relationship for Therapeutic Monoclonal Antibodies in Immuno‐Oncology and Beyond: Challenges, Perspectives, and Prospects. Issue 6 (2nd August 2020)

Authors:: Dai, Haiqing Isaac; Vugmeyster, Yulia; Mangal, Naveen
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 108:Issue 6(2020)
Page Start:: 1156
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

4. Phase I Study of the Bifunctional Fusion Protein Bintrafusp Alfa in Asian Patients with Advanced Solid Tumors, Including a Hepatocellular Carcinoma Safety‐Assessment Cohort. (23rd April 2020)

Authors:: Doi, Toshihiko; Fujiwara, Yutaka; Koyama, Takafumi; Ikeda, Masafumi; Helwig, Christoph; Watanabe, Morihiro; Vugmeyster, Yulia; Kudo, Masatoshi
Journal:: Oncologist
Issue:: Volume 25:Number 9(2020)
Page Start:: e1292
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

5. Risk assessment of drug–drug interaction potential for bintrafusp alfa with cytochrome P4503A4 substrates: A totality of evidence approach. Issue 12 (6th October 2022)

Authors:: Vugmeyster, Yulia; Locke, George; Helwig, Christoph; Rolfe, P. Alexander; Dong, Jennifer Q.; Venkatakrishnan, Karthik
Journal:: Clinical and translational science
Issue:: Volume 15:Issue 12(2022)
Page Start:: 2838
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

6. Selection of the Recommended Phase 2 Dose for Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF‐β and PD‐L1. Issue 3 (3rd March 2020)

Authors:: Vugmeyster, Yulia; Wilkins, Justin; Koenig, Andre; El Bawab, Samer; Dussault, Isabelle; Ojalvo, Laureen S.; De Banerjee, Samrita; Klopp‐Schulze, Lena; Khandelwal, Akash
Journal:: Clinical pharmacology & therapeutics
Issue:: Volume 108:Issue 3(2020)
Page Start:: 566
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

7. Time‐Varying Clearance and Impact of Disease State on the Pharmacokinetics of Avelumab in Merkel Cell Carcinoma and Urothelial Carcinoma. (25th April 2019)

Authors:: Wilkins, Justin J.; Brockhaus, Brigitte; Dai, Haiqing; Vugmeyster, Yulia; White, Joleen T.; Brar, Satjit; Bello, Carlo L.; Neuteboom, Berend; Wade, Janet R.; Girard, Pascal; Khandelwal, Akash
Journal:: CPT: pharmacometrics & systems pharmacology
Issue:: Volume 8:Number 6(2019)
Page Start:: 415
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗